Eric Mosbrooker's most recent trade in Avidity Biosciences Inc was a trade of 50,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 6, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Avidity Biosciences Inc | Eric Mosbrooker | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
Avidity Biosciences Inc | Eric Mosbrooker | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 25,000 | 61,120 | - | 0 | Common Stock | |
Avidity Biosciences Inc | Eric Mosbrooker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) |